-
Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)
(PAR-22-058)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
-
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
(PAR-22-075)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): January 7, 2025
-
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
(PAR-22-083)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
(PAR-22-084)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
(PAR-22-099)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
(PAR-22-102)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional)
(PAR-22-103)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U01 Clinical Trial Not Allowed)
(RFA-AI-22-002)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): May 13, 2022
-
Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U19 Clinical Trial Not Allowed)
(RFA-AI-22-003)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): May 13, 2022
-
HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed)
(RFA-DE-22-011)
National Institute of Dental and Craniofacial Research
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Center for Advancing Translational Sciences
Application Receipt Date(s): March 31, 2022
-
Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
(RFA-DK-22-005)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): May 17, 2022
-
Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)
(RFA-ES-22-002)
National Institute of Environmental Health Sciences
Application Receipt Date(s): June 9, 2022
-
Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs (U2F) Clinical Trials Not Allowed
(RFA-FD-22-009)
Food and Drug Administration
Application Receipt Date(s): April 4, 2022, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Revision Applications - Development and Maintenance of the Animal Feed Regulatory Program Standards Flexible Funding Model Compliance and Enforcement Expansion Supplement (U18) [Clinical Trials Not Allowed]
(RFA-FD-22-010)
Food and Drug Administration
Application Receipt Date(s): April 4, 2022, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Revision Applications - Manufactured Food Flexible Funding Model Compliance and Enforcement Expansion Supplement (U18) [Clinical Trials Not Allowed
(RFA-FD-22-019)
Food and Drug Administration
Application Receipt Date(s): April 4, 2022
-
Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional)
(RFA-HD-22-024)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Application Receipt Date(s): April 18, 2022
-
Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed)
(RFA-HG-22-004)
National Human Genome Research Institute
Application Receipt Date(s): July 1, 2023
-
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed)
(RFA-HL-23-001)
National Heart, Lung, and Blood Institute
National Institute of General Medical Sciences
Application Receipt Date(s): June 17, 2022
-
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed)
(RFA-HL-23-002)
National Heart, Lung, and Blood Institute
National Institute of General Medical Sciences
Application Receipt Date(s): June 17, 2022
-
Stimulating Access to Research in Residency (StARR) (R38)
(RFA-HL-23-006)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Eye Institute
Application Receipt Date(s): May 16, 2024
-
Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 Clinical Trial Optional)
(RFA-MD-22-007)
National Institute on Minority Health and Health Disparities
National Institute of Mental Health
Office of Disease Prevention
Application Receipt Date(s): March 28, 2022
-
Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)
(RFA-MH-22-110)
National Institute of Mental Health
Application Receipt Date(s): June 10, 2022
-
Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed)
(RFA-MH-22-111)
National Institute of Mental Health
Application Receipt Date(s): June 10, 2022
-
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
(RFA-MH-22-145)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Multiple dates, see announcement.
-
Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
(RFA-MH-22-175)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): March 18, 2022
-
Emergency Award HEAL Initiative: Developing and Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
(RFA-MH-22-176)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): March 18, 2022
-
HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required)
(RFA-NS-22-037)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
Office of Research on Women's Health
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Application Receipt Date(s): March 22, 2022
-
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
(RFA-TR-22-011)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Application Receipt Date(s): April 16, 2023
-
Emergency Awards: HEAL Initiative-Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Research Network (ERN) (U24 Clinical Trial Not Allowed)
(RFA-TR-22-012)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Complementary and Integrative Health
Application Receipt Date(s): March 15, 2022
-
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
(RFA-TR-22-013)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Application Receipt Date(s): April 18, 2023